MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    A scoping review of safer mobility behaviour for falls prevention: Implications for people with Parkinson’s disease.

    D. Cheung, J. Wesson, S. Paul, L. Mackenzie, L. Goh, C. Canning, L. Almeida, M. Enright, N. Allen (Camperdown, Australia)

    Objective: To map out the definition and concepts of safer mobility behaviour and how it is applied through assessment and intervention for fall prevention in…
  • 2025 International Congress

    Stretegy of self-care in patient with Parkison disease: a metasynthesis

    M. Petralito, C. Tedesco, I. Milani, G. Pucciarelli, R. Caruso (Roma, Italy)

    Objective: The purpose of this study is to synthesize the literature on self-care strategies implemented by patients with idiopathic Parkinson’s disease. Background: Parkinson’s disease presents…
  • 2025 International Congress

    Improving Vocal Volume and Quality of Life for People with Parkinson’s Disease (PD) utilizing EMST and SPEAK OUT!® in the In-Patient Multimodal Intensive Neurorehabilitation And Care Setting.

    P. Fischetti, J. Yu, M. Mccrossin, L. Rubin (Glen Cove, USA)

    Objective: To demonstrate the ability to improve vocal volume and improve perceived disability and quality of life in PD patients at the unstructured conversational level during…
  • 2025 International Congress

    Clinician Advisory Community: Guiding The Michael J. Fox Foundation’s Mission Through Front-Line Intelligence

    R. Dolhun, D. Kumbroch, K. Klapper, K. Wu, L. Holding, K. Callahan (New York, USA)

    Objective: Create a survey-ready community of U.S.-based clinicians to share care-focused inputs that inform The Michael J. Fox Foundation’s (MJFF) research funding and recruitment, policy,…
  • 2025 International Congress

    Long-Term Benefits of Weekly Group Physiotherapy in Slowing Parkinson’s Progression:A 12-Month Non-Randomized Controlled Trial

    E. Tardelli, M. Piemonte, B. Rosa, P. Igarashi, C. Dias (São Paulo, Brazil)

    Objective: To investigate the effects of weekly group PT programs to reduce the progression of motor symptoms severity in PwPD Background: The short-term benefits of…
  • 2025 International Congress

    G-Can, the GBA1 Canada Initiative

    L. Chebon, P. Halder, E. Fon, T. Durcan, M. Parent, N. Dupre, M. Sharp, R. Postuma, G. Armstrong, A. Milnerwood, A. Dagher, J. Raamsdonk, J. Trempe, T. Goldsmith, X. Chen, N. Aprahamian, Z. You, M. Nicoleau, E. Deneault, A. Bayne, C. Laflamme, P. Mcpherson, M. Pandolfo, G. Rouleau, Z. Gan-Or (Québec, Canada)

    Objective: G-Can, the GBA1 Canada Initiative, is an open-science platform which aims to advance GBA1 research and develop treatments for GBA1 mutation-related Parkinson's disease (PD).…
  • 2025 International Congress

    The Benefits of Whole-Body Electro Muscle Stimulation (WB-EMS) in a patient with Parkinson’s Disease

    N. Duff, C. Cawood, M. Noble (Parktown, South Africa)

    Objective: To determine the motor and non-motor benefits of WB-EMS in a patient with Parkinson’s disease Background: Parkinson’s disease causes both motor and non-motor symptoms.…
  • 2025 International Congress

    A Comparison of Coordinated Reset and Low-Frequency Vibrotactile Stimulation for the Treatment of Parkinson’s Symptoms

    E. Kabasenche, M. Gutierrez, M. Fisher, C. Hauptmann, P. Luu, D. Tucker (Eugene, USA)

    Objective: This research examines a novel non-invasive vibrotactile device which stimulates fingertips in a pattern aiming to disrupt pathological physiological beta-band oscillations believed to be…
  • 2025 International Congress

    Enrollment Challenges and Strategies in Early-Stage Parkinson’s Disease Clinical Trials: Comparing Treatment-Naïve and Previously Treated Patient Populations

    J. Roberts, A. Lysandropoulos (Durham, USA)

    Objective: To evaluate enrollment rates and challenges in clinical trials of disease-modifying therapies (DMTs) for early-stage Parkinson's disease (PD), comparing treatment-naïve patients with those permitted prior symptomatic…
  • 2025 International Congress

    Effects of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Motor Complications in Parkinson’s Disease

    E. Tharp, J. Martinez-Lemus, C. Onuigbo, T. Thomas, C. Green, J. Suescun, T. Le, E. Rodarte, R. Ritter Iii, T. Ellmore, M. Schiess (New York, USA)

    Objective: To evaluate the impact of intravenous (IV) allogeneic bone marrow-derived mesenchymal stem cell (allo-hMSC) treatment on motor complications in Parkinson’s disease (PD). Background: Motor…
  • « Previous Page
  • 1
  • …
  • 205
  • 206
  • 207
  • 208
  • 209
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley